24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
CVS
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
13:43
EU approves Nvidia’s $700M acquisition of Israeli startup Run:ai
21:16
Nervio appoints Dr. Richard Vogel as US CEO
19:06
Paragon’s $900M sale in limbo as Defense Ministry steps in
15:05
Full list of Israeli high-tech funding rounds in 2024
More stories
Buzz
Most popular
Daily
Weekly
1
Israeli tech’s top 10 funding rounds of 2024: Wiz sets another record
2
EU approves Nvidia’s $700M acquisition of Israeli startup Run:ai
3
Boomi acquires Israeli data management startup Rivery in $100M deal
4
The Wiz of GenAI security? “Lasso has the potential to be a once-in-a-decade company in cyber”
5
Decart raises $32M in second funding round in two months, aims to rival OpenAI and Anthropic
More news
CVS
1 stories about CVS
CVS Picks Migraine Drugs by Teva, Eli Lilly, Snubs Amgen, Reuters Reports
27.01.19
|
Lilach Baumer
In October, American prescription benefits management company Express Scripts added Amgen and Eli Lilly’s drugs to its coverage but excluded Teva
Please ensure Javascript is enabled for purposes of
website accessibility
